Wei Xia
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 10%
Papers in
- Oncology 12
- Lung Cancer Research Studies 3
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Philip S. Low (6 shared papers)Ji‐Xin Cheng (1 shared paper)Eric L. Matteson (1 shared paper)Khalid Rahman (2 shared papers)Wei Yue (1 shared paper)Yanxi Zhou (1 shared paper)Cheng Yun Peng (1 shared paper)Albert Chi Yan Chan (2 shared papers)
- Journals
- CHEST Journal (4 papers)Transplantation (2 papers)Oncotarget (2 papers)Molecular Pharmaceutics (2 papers)Journal of Investigative Medicine (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Xia
46 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 109
- Biomaterials 227
- Cancer Research 172
- Oncology 280
- Molecular Biology 680
- Rheumatology 140
Countries citing papers authored by Wei Xia
This map shows the geographic impact of Wei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xia more than expected).
Fields of papers citing papers by Wei Xia
This network shows the impact of papers produced by Wei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xia. The network helps show where Wei Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 432 | |
| 2 | 2008 | 279 | |
| 3 | 2018 | 166 | |
| 4 | 2015 | 161 | |
| 5 | 2017 | 63 | |
| 6 | 2005 | 61 | |
| 7 | 2020 | 61 | |
| 8 | 2018 | 48 | |
| 9 | 2014 | 47 | |
| 10 | 2014 | 46 | |
| 11 | 2021 | 40 | |
| 12 | 2015 | 38 | |
| 13 | 2018 | 31 | |
| 14 | 2002 | 27 | |
| 15 | 2022 | 25 | |
| 16 | 2003 | 22 | |
| 17 | 2012 | 22 | |
| 18 | 2012 | 20 | |
| 19 | 2018 | 20 | |
| 20 | 2022 | 20 |
About Wei Xia
Wei Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Immunology and Cancer Research, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (9 papers), Lung Cancer Research Studies (3 papers), Immune cells in cancer (3 papers), Folate and B Vitamins Research (3 papers), Respiratory viral infections research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Ferroptosis and cancer prognosis (3 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Biomaterials (227 citations), Cancer Research (172 citations), Oncology (280 citations), Molecular Biology (680 citations) and Rheumatology (140 citations). Wei Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Philip S. Low, Ji‐Xin Cheng, Eric L. Matteson, Khalid Rahman, Wei Yue, Yanxi Zhou, Cheng Yun Peng, Albert Chi Yan Chan, Yanan Song and Xiao Qi Wang. Their work appears in journals such as CHEST Journal, Transplantation, Oncotarget, Molecular Pharmaceutics and Journal of Investigative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.